Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1992-09-04
1999-03-23
Raymond, Richard L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514 63, 514 81, 514183, A61K 31695, A61K 31675, A61K 3140, A61K 31395
Patent
active
058860177
ABSTRACT:
Compositions of matter and pharmaceutical compositions having protein kinase C-modulatory, anti-inflammatory, anti-viral and other activities are disclosed. The compounds are derived from tricyclic aromatic heterocyclic compounds incorporating indole, indene, benzofuran and benzothiophene structural elements.
REFERENCES:
patent: 4376821 (1983-03-01), Braude
patent: 4376822 (1983-03-01), Braude
patent: 4401756 (1983-08-01), Gillis
patent: 4460685 (1984-07-01), Vilcek et al.
patent: 5145842 (1992-09-01), Driedger et al.
patent: 5570568 (1998-05-01), Driedger et al.
patent: 5643948 (1997-07-01), Driedger et al.
patent: 5716968 (1998-02-01), Driedger et al.
Connolly et al, Antimicrob. Agents. Chemother. p. 245 (1992).
Saari et al, J Med. Chem 1992, 35. 3792-3802.
Mansuri et al, Chemtech. 1992, p. 564.
Merck Standby Statement, Sep. 14, 1993.
Dr. Sandstrom Letter of Jun. 19, 1990.
Kemp et al, Science 238: 1726 (1987).
Tinker et al, J. Biol. Chem. 263: 5024 (1998).
Wise et al, J. Biol. Chem. 257: 8489 (1982).
Loomis et al, J. Biol. Chem. 263: 1682 (1988).
Schatzman et al, Biochem. Biophy. Res. Comm. 98: 669 (1981).
Tamaoki et al. Biochem. Bioph. Res. Comm: 135: 397 (1986).
Srivastara, Biochem. Bioph. Res. Comm. 131:1 (1985).
Hidaka et al, Biochemistry 23:5036 (1984).
Mitsuya et al, AIDS, Modern Concepts and Therapeutic Challenges, Chapter 18, pp. 303-333 (1987).
J.A. Dunn and P.M. Blumberg, Cancer Res., 43: 4632-4637 (1983).
T. Sugimura, Gann, 73: 499-507 (1982).
Y. Endo et al., Chem. Pharm. Bull. 32: 358-361 (1984).
E. Hecker and R. Schmidt, Fortschritte D. ChemieOrganischer Naturstoffe 31: 377-467 (1974).
F.J. Evans and C.J. Soper, Lloydia 41: 193-233 (1978).
R. Schmidt and E. Hecker, Aktuelle Problems aus dem Gebiet der Cancerologie III, pp. 98-108 (1971).
D. Uemura, H. Ohwaki and Y. Hirata, Tetrahedron 29: 2527-2528 (1974).
D. Uemura and Y. Hirata, Tetrahedron 29: 2529-2532 (1974).
Y. Hirata, Pure and Appl. Org. Chem. 11: 176-199 (1975).
S. Kupchan et al., Science 191: 571-572 (1976).
F. Evans, Toxicon 16: 51-57 (1978).
K. Sakata, et al., Tetrahedron 16: 1141-1144 (1971).
S. Kupchan et al., JACS 97:672-673 (1975).
S. Kupchan et al. JACS 98: 5719-5720 (1976).
S. Zayed et al., Tetrahedron 39: 3481-3482 (1977).
G. Stout et al., JACS 92: 1070-1071 (1970).
G. Furstenberger and E. Hecker, Experientia 33: 986-988 (1977).
J. Coetzer and M.J. Pieterse, J. South Afr. Chem. Inst. 24: 241-243 (1971).
H.-W. Thielmann et al., Liebigs Ann. Chem. 728: 158-183 (1969).
H.-W. Thielmann et al., Forschritte der Krebsforschung, Vo. VII, pp. 171-179, New York: Schattauer, 1969.
E. Hecker, Carcinogenesis, vol. II. Mechanisms of Tumor Promotion and Carcinogenesis, pp. 11-48. New York: Raven Press, 1978.
R. Schmidt and F. Evans, Arch. Toxicol. 44: 279-289 (1980).
H. Harada et al., Bull. Chem. Soc. Japan 39: 1773-1775 (1966).
S.de Laszlo,et al., J. Chem. Soc., Chem. Commun., 344-346 (1986).
W. Adolf et al., J. Natural Prod. 45: 347-354 (1982).
W. Adolf and E. Hecker, J. Med. Plant Res. 45: 177-182 (1982).
E. Seip and E. Hecker, J. Med. Plant Res. 46: 215-218 (1982).
H. Opferkuel et al., Z. Naturforsch 36: 878-887 (1982).
B. Sorg and E. Hecker, Z. Naturforsch 37: 748-756 (1982).
B. Sorg and E. Hecker, Z. Naturforsch 37 1640-1647 (1982).
A. Jeffrey and R. Liskamp, Proc. Natl. Acad. Sci. USA 83: 241-245 (1986).
Y. Nishizuka, Nature 308: 693-698 (1984).
Y. Nishizuka, Science 225: 1365-1370 (1984).
P. Driedger and P. Blumberg, Cancer Research 39: 714-719 (1979).
P. Driedger and P.M. Blumberg, Cancer Research 37: 3257-3265 (1977).
B. Ganong et al., Proc. Natl Acad. Sci. 83: 1184-1188 (1986).
R. Schmidt and E. Hecker, Carcinogenesis 7: 57-63 (1982).
T. Horiuchi et al., Gann 75: 837-840 (1984).
K. Irie et al., Int. J. Cancer 36: 485-488 (1985).
P. Wender et al., Proc. Natl. Acad. Sci. 83: 4214-4218 (1986).
T. Kakunaga et al., Cellular Interactions by Environmental Tumor Promoters, pp. 303-313. Tokyo: Japan Sci. Soc. Press, 1984.
F.J. Evans, Naturally Occurring Phorbol Esters, pp. 171-215. Boca Raton: CRC Press, 1986.
R. Schmidt, Naturally Occurring Phorbol Esters, pp. 217-243. Boca Raton: CRC Press, 1986.
R. Schmidt, Naturally Occurring Phorbol Esters, pp. 245-269. Boca Raton: CRC Press, 1986.
K. Irie et al, Agric. Biol. Chem. 49: 1441-1446 (1985).
R. Liskamp et al., BBRC 131: 920-927 (1985).
Yasutomi Nishizuka, Science, vol. 233 (1986) p. 305.
Yasutomi Nishizuka, Nature, vol. 334 (1988) p. 661.
Kazuhiro Irie et al., Carcinogenesis, vol. 8, No. 4 (1987) pp. 547-552.
Shin-ichi Nakatsuka et al., Tetrahedron Letters, vol. 28, No. 32 (1987) pp. 3671-3674.
Hirota, Fujiki et al., Gann, 75: 866-870 (1984).
Kazuhiro Irie et al., Argic. Biol. Chem. (50(10): 2679-2680 (1986).
Shin-ichiro Sakai et al., Chem. Pharm. Bull 34(11): 4883-4886 (1986).
Matao Takashima et al., Arg. Biol. Chem., vol. 26, No. 10, p. 660 (1962).
Yasuyuki Endo et al., Tetrahedron Letters, vol. 43, No. 10, p. 2241 (1987).
Kazuhiro Irie et al., Agric Biol. Chem., 48(5): 1269-1274 (1984).
Kazuhiro Irie et al., Tetrahedron Letters, vol. 43, No. 22, pp. 5251-5260 (1987).
Yasutomi Nishizuka, JAMA, vol. 262, No. 13, p. 1826 (1989).
Chemical Abstracts, vol. 70, No. 11, 17 Mar. 1969, (Columbus, OH, US); abstract No. 47622q.
A.P. Kozikowski et al., J. Am. Chem. Soc., vol. 111, No. 16, pp. 6228-6234 (2 Aug. 1989), "Synthesis and Biological Studies of Simplified Analogues of Lyngbyatoxin A: Use of an Isoxazoline-based indole synthesis. Quest for protein kinase C modulators".
Driedger Paul E.
Quick James
Procyon Pharmaceuticals, Inc.
Raymond Richard L.
LandOfFree
Protein kinase C modulators. E. does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Protein kinase C modulators. E., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Protein kinase C modulators. E. will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2125744